Moleculin Reports Cardiac Safety Data for Annamycin
HOUSTON — September 28, 2026 Moleculin Biotech, Inc. announced publication of a peer-reviewed pooled analysis of the cardiac safety...
Phase 2/3
Advertisement
Vertex Reports Positive Inaxaplin Results in Kidney Disease
Boston, Massachusetts, U.S., September 22, 2026 Vertex Pharmaceuticals Incorporated has announced positive results from the Phase 2b AMPLIFIED study...
Quoin Gains FDA Fast Track for QRX003 in Peeling Skin Syndrome
ASHBURN, Va. — September 22, 2026 Quoin Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast...
Beacon Therapeutics Reports Positive VISTA Data for Laru-zova
LONDON and CAMBRIDGE, Mass September 21, 2026 — Beacon Therapeutics announced positive topline results from the pivotal VISTA trial...
Biohaven, SK Biopharmaceuticals Sign Global Opakalim Deal
NEW HAVEN, Conn. and SEOUL, South Korea, Aug. 26, 2026 Biohaven Ltd. and SK Biopharmaceuticals announced a strategic global...
Advertisements
Abcuro Raises $66M to Advance IBM Therapy
Newton, Massachusetts, August 18, 2026 Abcuro, Inc. has announced the closing of a $66 million Series D financing to...
Moleculin Reports Positive MIRACLE Trial Results
HOUSTON, July 6, 2026 Moleculin Biotech announced that Chairman and Chief Executive Officer Walter Klemp discussed encouraging preliminary results...
Compass Therapeutics Nears Key Data for Tovecimig in BTC
Boston, Massachusetts | April 24, 2026 Compass Therapeutics has announced it will present topline secondary endpoint data from its...
Advertisement
